These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 24633743)
21. 'Did He Who Made the Lamb Make Thee?' New Developments in Treating the 'Fearful Symmetry' of Acute Myeloid Leukemia. Brumatti G; Lalaoui N; Wei AH; Silke J Trends Mol Med; 2017 Mar; 23(3):264-281. PubMed ID: 28196625 [TBL] [Abstract][Full Text] [Related]
34. Management of primary refractory acute myeloid leukemia in the era of targeted therapies. McMahon CM; Perl AE Leuk Lymphoma; 2019 Mar; 60(3):583-597. PubMed ID: 30234399 [TBL] [Abstract][Full Text] [Related]
35. FLT3 inhibitors for acute myeloid leukemia: a review of their efficacy and mechanisms of resistance. Grunwald MR; Levis MJ Int J Hematol; 2013 Jun; 97(6):683-94. PubMed ID: 23613268 [TBL] [Abstract][Full Text] [Related]
36. [Research Advances on Targeted Therapy for Acute Myeloid Leukemia--Review]. He HT; Li HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):245-9. PubMed ID: 26913430 [TBL] [Abstract][Full Text] [Related]
37. Coordinate PI3K pathway and Bcl-2 family disruption in AML. Bose P; Rahmani M; Grant S Oncotarget; 2012 Dec; 3(12):1499-500. PubMed ID: 23439314 [No Abstract] [Full Text] [Related]
38. Therapeutically targeting SELF-reinforcing leukemic niches in acute myeloid leukemia: A worthy endeavor? Bernasconi P; Farina M; Boni M; Dambruoso I; Calvello C Am J Hematol; 2016 May; 91(5):507-17. PubMed ID: 26822317 [TBL] [Abstract][Full Text] [Related]